newsfilter
← Latest News
GlobeNewswire·

Sanofi to acquire Kadmon to further strengthen growth of transplant business

Sanofi to acquire Kadmon to further strengthen growth of transplant business Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD)